BRPI0813298A2 - Complexos nano-conjugados de ácidos nucléicos, avidina e polímeros; uso e preparação dos mesmos. - Google Patents
Complexos nano-conjugados de ácidos nucléicos, avidina e polímeros; uso e preparação dos mesmos.Info
- Publication number
- BRPI0813298A2 BRPI0813298A2 BRPI0813298-4A2A BRPI0813298A BRPI0813298A2 BR PI0813298 A2 BRPI0813298 A2 BR PI0813298A2 BR PI0813298 A BRPI0813298 A BR PI0813298A BR PI0813298 A2 BRPI0813298 A2 BR PI0813298A2
- Authority
- BR
- Brazil
- Prior art keywords
- avidine
- nano
- preparation
- nucleic acid
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
- A61K47/557—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells the modifying agent being biotin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Saccharide Compounds (AREA)
- Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000223A ITPD20070223A1 (it) | 2007-06-29 | 2007-06-29 | Complessi nanoassemblati di acidi nucleici, avidina e polimeri, loro uso e preparazione |
PCT/EP2008/058298 WO2009003951A1 (en) | 2007-06-29 | 2008-06-27 | Nanoassembled complexes of nucleic acids, avidin and polymers, use and preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0813298A2 true BRPI0813298A2 (pt) | 2014-12-30 |
Family
ID=39864795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0813298-4A2A BRPI0813298A2 (pt) | 2007-06-29 | 2008-06-27 | Complexos nano-conjugados de ácidos nucléicos, avidina e polímeros; uso e preparação dos mesmos. |
Country Status (9)
Country | Link |
---|---|
US (1) | US8486639B2 (pt) |
EP (1) | EP2173904B9 (pt) |
JP (1) | JP2010531652A (pt) |
CN (1) | CN101730749A (pt) |
BR (1) | BRPI0813298A2 (pt) |
CA (1) | CA2691677A1 (pt) |
IL (1) | IL202872A0 (pt) |
IT (1) | ITPD20070223A1 (pt) |
WO (1) | WO2009003951A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITPD20130210A1 (it) | 2013-07-26 | 2015-01-27 | Ananas Nanotech S R L | Complessi nanoassemblati di acidi nucleici, avidina e composti biotinilati per uso come vettori per il trasporto intracellulare |
ITUB20152058A1 (it) * | 2015-07-10 | 2017-01-10 | Jointherapeutics S R L | Complessi nanoassemblati di acidi nucleici, avidina e composti biotinilati impiegabili per il trasporto di farmaci |
IT201900002679A1 (it) * | 2019-02-25 | 2020-08-25 | Livera S R L | Complessi nanoassemblati di acidi nucleici, avidina e composti biotinilati per l’uso nel trattamento patologie epatiche |
-
2007
- 2007-06-29 IT IT000223A patent/ITPD20070223A1/it unknown
-
2008
- 2008-06-27 US US12/667,116 patent/US8486639B2/en active Active
- 2008-06-27 BR BRPI0813298-4A2A patent/BRPI0813298A2/pt not_active Application Discontinuation
- 2008-06-27 JP JP2010513943A patent/JP2010531652A/ja active Pending
- 2008-06-27 CA CA002691677A patent/CA2691677A1/en not_active Abandoned
- 2008-06-27 WO PCT/EP2008/058298 patent/WO2009003951A1/en active Application Filing
- 2008-06-27 EP EP08774460A patent/EP2173904B9/en active Active
- 2008-06-27 CN CN200880022350A patent/CN101730749A/zh active Pending
-
2009
- 2009-12-21 IL IL202872A patent/IL202872A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2691677A1 (en) | 2009-01-08 |
IL202872A0 (en) | 2011-08-01 |
EP2173904B1 (en) | 2012-10-10 |
WO2009003951A1 (en) | 2009-01-08 |
EP2173904A1 (en) | 2010-04-14 |
US20100197032A1 (en) | 2010-08-05 |
EP2173904B9 (en) | 2013-02-20 |
ITPD20070223A1 (it) | 2008-12-30 |
JP2010531652A (ja) | 2010-09-30 |
US8486639B2 (en) | 2013-07-16 |
CN101730749A (zh) | 2010-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0806589A2 (pt) | Catalisador, sua preparação e uso. | |
BRPI0907453A2 (pt) | Compostos, uso e preparação dos mesmos | |
BRPI0922435A2 (pt) | "composto de tiazolopiridina moduladores de sirtuina, composição farmacêutica compreendendo o mesmo e seu uso." | |
BRPI0614205A2 (pt) | composto, composição farmacêutica, e, uso de composto | |
BRPI0821276A2 (pt) | Produto, e, uso do produto | |
BRPI0618904A2 (pt) | composto, composição farmacêutica, e, uso do composto | |
BRPI0815807A2 (pt) | Composição de ativadores de catalisador de aluminoxanos derivados dos agentes precursores do cátion dialquilalumínio, processos para fazer os mesmos, e sua utilização em catalisadores e polimerização de olefinas. | |
BRPI0815709A2 (pt) | composro, composição farmacêutica, e, uso de um composto. | |
BRPI0813455A2 (pt) | Derivado de 17beta-ciano-18a-homo-19-nor-androst-4-eno, seu uso e medicamentos contendo este derivado. | |
BRPI0811635A2 (pt) | Compostos de arilazol-2-il cianoetilamino, métodos para fazê-los e métodos para o uso dos mesmos | |
BRPI0722081A2 (pt) | Complexo metálico, composto polimérico e dispositivo contendo os mesmos | |
BRPI0905663A2 (pt) | "emulsão estável, processo de preparação da emulsão estável e uso emulsão" | |
BRPI0812831A2 (pt) | Composições de revestimento compreendendo polímeros de polissiloxano organofuncionais, e seu uso | |
BR112012003792A2 (pt) | gel tópico, e, uso do gel tópico. | |
BRPI0908504A2 (pt) | Compostos derivados de 3-metil-imidazo[1,2-b]piridazina, uso dos mesmos e composição farmacêutica | |
BRPI0718192A2 (pt) | Corantes dispersos, sua preparação e seu uso. | |
BRPI0813225A2 (pt) | Catalisador de craqueamento catalítico e preparação e uso do mesmo. | |
BRPI0907572A2 (pt) | Derivados de fluorglicosídeos aromáticos, fármacos compreendendo os referidos compostos e uso dos mesmos | |
BRPI0908097A2 (pt) | uso de pelo menos um composto, peptídeo, e, formulação farmacêutica. | |
CL2007002377A1 (es) | Compuestos derivados de quinazolina; procedimiento de preparacion; composicion farmaceutica; y su uso como anticancerigeno. | |
CL2008001069A1 (es) | Compuestos derivados de tetrahidroindazoles y tetrahidroindoles; procedimiento de preparacion; y su uso para tratar una enfermedad o trastorno relacionado con la proliferacion celular. | |
BRPI0813341A2 (pt) | " uso de compostos, composições curáveis, e, uso de composições curáveis ". | |
DK1883469T3 (da) | Katalysatorfremstilling | |
BRPI0913175A2 (pt) | artigo antibalístico, e, uso do mesmo. | |
BRPI0812766A2 (pt) | 4-cloro-4-alcóxi-1,1,1-triflúor-2-butanonas, preparação das mesmas e uso das mesmas no preparo de 4-alcóxi-1,1,1-triflúor-3-buten-2-onas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |